NoneProspera Financial Services Inc Has $710,000 Stake in iShares Treasury Floating Rate Bond ETF (NYSEARCA:TFLO)Honeywell International Inc has cut its annual guidance due to a partnership with Bombardier aircraft, which is expected to increase investment costs. The company's adjusted earnings per share for Q4 and FY 2024 have been lowered, with Q4 adjusted EPS now expected to be between $2.26 and $2.36, down from a prior forecast of $2.73 to $2.83. Sales guidance for Q4 and FY 2024 have also been reduced. Despite the short-term impact, Honeywell believes the partnership will lead to long-term value creation for its shareholders. Investin.com -- Honeywell International Inc (NASDAQ:HON) cut its annual guidance on Monday after the jet engine maker struck an investment-heavy partnership with Bombardier aircraft that is expected to keep a lid on its bottom line. Honeywell International Inc (NASDAQ:HON) fell 3% in afterhours following the news. Under the collaboration, Honeywell said ti would provide "advanced technology for current and future Bombardier (OTC:BDRBF) aircraft in avionics, propulsion and satellite communications technologies." The agreement is expected to dent adjusted earnings per share by $0.47 and sales by $0.4 billion, the company said as it lowered guidance for Q4 and FY 2024. The company said it now sees Q4 adjusted earnings per share in a range of $2.26 of $2.36, down from a prior forecast for adjusted EPS of $2.73 to $2.83. Sales for Q4 were cut to a range of $9.8B to $10.0B from $10.2B to $10.4B. For the full-year, adjusted EPS was expected in a range of $9.68 to $9.78, down from a prior forecast of $10.15 to $10.25. Sales guidance for Q4 was cut to a range of $38.2B to $38.4B from $38.6B to $38.8B. "While the commercial agreement impacts near-term Honeywell financials, the company is confident it will lead to long-term value creation for Honeywell shareowners," Honeywell said. Related Articles Honeywell cuts guidance as Bombardier partnership to lift investment costs Janux shares surge on promising JANX007 prostate cancer trial UBS starts coverage on gov service providers stock amid spending uncertainty
NEVADA 90, OKLAHOMA STATE 78
With the election mercifully behind us, Americans should expect those we’ve elected to get to the less-pleasant task of governing responsibly. While hot-button issues such as immigration, inflation and foreign affairs will garner most headlines, a more pressing concern is too often overlooked: America’s staggering national debt. Growing faster than the economy and projected to reach a record share of gross domestic product (GDP) within three years, our debt is a national crisis. If we continue down the current unsustainable path, we are flirting with catastrophe that would dwarf the Great Recession of 2007-2009. Our next Congress and President must confront this challenge before it is too late. The current debt held by the public stands at $28 trillion or 98% of GDP. In three years, that debt will exceed the record of 106% of GDP reach just after World War 2. However, the WW2 debt was incurred for a specific, important purpose: to preserve freedom and democracy. Within a decade, it was sliced in half. Today’s debt is mostly the result of irresponsible budgeting by both parties, years of passing deficit-ridden budgets because our leaders are unwilling to even modestly slow federal spending. This fiscal negligence and generational theft is the tip of the iceberg. In just a decade, debt held by the public is projected to reach $52 trillion or 122% of GDP. Failing to act will trap future generations in a cycle of high debt and diminished economic opportunity. This moral failure lets us live high on the hog today while passing the buck our children and grandchildren who have no voice in today’s decisions. National debt always seems like a number so enormous it’s hard to comprehend, but it directly affects us in profound ways. As the debt grows, so do interest payments. In 2024, interest payments on our nation’s debt will exceed spending on Medicare, defense, and all programs earmarked for children. That’s the price we pay today for irresponsible spending of the past. However, each year’s deficit adds to the debt and to the cost of financing it. Excessive borrowing by government drives up interest rates and makes borrowing more expensive for businesses seeking to grow or families striving to buy a home. This makes everyday goods more expensive and raises borrowing costs for consumer loans. High debt leads to slower economic growth, higher inflation rates and fewer opportunities for businesses and workers to prosper. Soaring national debt also threatens our national security. The higher our debt, the less financial flexibility we have to respond to emergencies. Whether facing a pandemic, natural disaster or security crisis, a nation severely in debt lacks resources to react swiftly and decisively. Excessive debt also opens the door to potential financial entanglement with foreign leaders who may not share our priorities or interests. Our adversaries shrewdly search for ways to pressure us to compromise American values and sovereignty. Maintaining a strong national defense, stable economy and reliable public safety is essential to our security. A balanced, responsible fiscal approach with broad public acceptance is essential. Reining in the national debt is not about austerity or simply cutting programs. It is about creating a balanced approach that secures our future. Social Security and Medicare, which together form a substantial portion of the federal budget, are on track to face insolvency within 12 years. Responsible reforms would protect these programs for future generations. Both political parties must find common ground and commit to a long-term strategy that includes prudent spending cuts and targeted investments to strengthen the economy. Solving our debt crisis will require tough choices and a willingness to look beyond the next election cycle to do what’s right for our country. The next Congress and President-elect Trump must take meaningful steps to address our national debt. Republicans have an opportunity to seek out those Democrats who also realize the danger of habitually kicking the problem past the next election – a practice that must end. Coloradans can lead in finding solutions. In the House, six of Colorado’s eight returning or incoming Representatives are parents of young children upon whom Congress has piled trillions in debt. That should motivate them to seek common ground on this growing threat to our future. Curtailing the debt is like planting a tree. The best time to do it was ten years ago. The next-best time is now. Mark Hillman served as Senate Majority Leader and State Treasurer.
Arkansas visits skidding Miami in battle of veteran coachesEl Salvador's Congress approves ending ban on metals mining
Instacart CEO Focuses on Grocery Partnerships as Firm’s Value Drops
Daily Post Nigeria Man kills bosom friend in Delta over N30m Home News Politics Metro Entertainment Sport Metro Man kills bosom friend in Delta over N30m Published on December 23, 2024 By Alex Akinrogbe A suspect, identified as Efe Onoetiyi, and others have been arrested by the police over the murder of one Paulinus Okon. Earlier, Paulinus had been reported missing on September 8, 2024, by his brother, after he went out with his friend, Onoetiyi Efe, a 30-year-old male. Efe, who initially denied knowing anything about Paulinus’s disappearance, later visited Paulinus’s family. When confronted with the fact that Paulinus had gone out with him on that same day, Efe denied this. Later, he returned and demanded N500,000 from Paulinus’s brother, claiming he would use the money to consult a herbalist who could help them locate Paulinus. Efe also informed the family that Paulinus had been kidnapped and collected a ransom of approximately N20,715,000 from Paulinus’s brother, claiming he was in contact with the kidnappers. When it became clear that Efe was hiding something, he was arrested, and the case was transferred to the State Criminal Investigation Department at the State Headquarters in Asaba. The Commissioner of Police, Delta Command, Abaniwonda Olufemi, on November 28, 2024, directed the DPO of Ekpan to take over the case and ensure a thorough investigation is carried out to identify those responsible, as the main suspect, Efe, was not cooperating. Ekpan conducted an intelligence-led investigation that led to the indictment of one Okeimute Gaga, 48. Upon arrest, Okeimute Gaga confessed, saying: “I can no longer hide what happened. I will narrate how Efe brought Paulinus to Orere River in Otokutu and asked us to kill him.” The suspect further stated that on September 8, 2024, he, Efe, Sunday Ikpeba, and a 30-year-old herbalist known as Lawrence Joseph tied Paulinus Okon to a stake at night near Orere River and beheaded him while he was still alive. “His body was thrown into the river while the herbalist took Paulinus’s head and buried it at his shrine in Otokutu,” he added. The DPO of Ekpan Police Station led police operatives to the shrine in Otokutu, where the skull of Paulinus was exhumed and recovered. Asked why he killed his friend, Efe said that he found a building for sale for N30,000,000, which he advertised to Paulinus. The deceased paid him N30,000,000 in three instalments, but instead of purchasing the house, Efe diverted the money for his personal use, buying two plots of land and building a duplex for himself. “I did not know how to explain to the deceased that I had used his money, so I decided that killing him would save me the trouble,” he confessed. According to the Commissioner of Police, Efe and the three other suspects are currently in custody. Related Topics: Delta Don't Miss Miscreants on rampage, 1 killed as police raid hard drugs joint in Calabar You may like Kingship tussle: Delta court convicts 9 in forgery case Yuletide: Delta Police Command restates ban on fireworks Three men to die by hanging for abducting, killing Delta monarch Police arrest 36-year-old man for allegedly raping married woman in Delta Human trafficking: Delta govt to confiscate motor parks, jail operators Anioma monarchs endorse move for separate state from Delta Advertise About Us Contact Us Privacy-Policy Terms Copyright © Daily Post Media LtdTrump selects longtime adviser Keith Kellogg as special envoy for Ukraine and Russia
PLEASANTON, Calif. , Dec. 23, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from NanoString Technologies. To minimize the risk of disruption to ongoing research, 10x Genomics requested a carve-out for GeoMx users who installed an instrument prior to the trial in November 2023 . The injunction, which the Court said it will enter in January 2025 , is expected to prohibit Bruker from making, using, selling or offering to sell in the United States its GeoMx Digital Spatial Profiler and associated instruments, reagents and services for RNA and protein detection. At the request of 10x Genomics, the injunction will not block ongoing research by researchers who installed a GeoMx instrument prior to November 18, 2023 . Such customers can continue to purchase GeoMx reagents for use with existing GeoMx instruments for purposes of continuing their ongoing research. The Court found that making such an exception for ongoing research strikes a "workable balance between protecting the patentee's rights and protecting the public from the injunction's adverse effects." In addition, the Court affirmed the $31 million damages awarded by the November 2023 jury verdict, as well as supplemental damages and interest that will be added to the total damages when final judgment is entered. "Today's decision helps to safeguard our decade-long investment in innovation and ensures we can continue to develop groundbreaking technologies that help our customers revolutionize science," said Eric Whitaker , Chief Legal Officer at 10x Genomics. "10x exists to fuel scientific progress – not stifle it – and that is why we've done our utmost to ensure this injunction was structured to protect both our intellectual property and existing GeoMx customers' ongoing research." The Court recognized the harm NanoString's infringing conduct caused 10x when it wrote in its ruling, "Having been careful not to license its technology, 10x suffers when it proclaims itself as an innovator in spatial genomics but a competitor is using the same innovative, patented technology." Today's Court decision follows a November 2023 jury verdict that found that NanoString's GeoMx products willfully infringed seven patents exclusively licensed to 10x Genomics by Prognosys. During the trial, the jury heard testimony from the sole inventor of the patents, Illumina co-founder Mark Chee , and NanoString CEO Brad Gray and NanoString CSO Joe Beechem. After hearing all of the evidence, the jury determined that all seven patents had been infringed by NanoString, that each patent was valid, that NanoString willfully infringed those patents and that monetary damages were owed to 10x for the infringement of all seven patents. In affirming the jury's finding that NanoString willfully infringed, the Court relied on the evidence showing that NanoString knew or was willfully blind that its acts would cause infringement of 10x's rights. The asserted patents in Case No. 21-cv-653-MFK include (a) U.S. Patent No. 10,472,669; (b) U.S. Patent No. 10,961,566; (c) U.S. Patent No. 10,983,113; (d) U.S. Patent No. 10,996,219; (e) U.S. Patent No. 11,001,878; (f) U.S. Patent No. 11,008,607 and (g) U.S. Patent No. 11,293,917. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter) . Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. All statements included in this press release, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "might," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "see," "estimate," "predict," "potential," "would," "likely," "seek" or "continue" or the negatives of these terms or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include statements regarding litigation and remedies as well as possible outcomes of litigation. These forward-looking statements do not reflect that our success will depend on our ability to obtain, maintain and protect our intellectual property rights, intellectual property litigation could be expensive, time-consuming, unsuccessful and could interfere with our ability to develop, manufacture and commercialize our products or technologies, litigation outcomes are unpredictable or there may be changes in our litigation strategy. These statements are based on management's current expectations, forecasts, beliefs, assumptions and information currently available to management. Actual outcomes and results could differ materially from these statements due to a number of factors and such statements should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. The material risks and uncertainties that could affect 10x Genomics, Inc.'s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's most recently-filed 10-K for the fiscal year ended December 31, 2023 and elsewhere in the documents 10x Genomics, Inc. files with the Securities and Exchange Commission from time to time. Disclosure Information 10x Genomics uses filings with the Securities and Exchange Commission, our website ( www.10xgenomics.com ), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Contacts Investors: investors@10xgenomics.com Media: media@10xgenomics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/us-district-court-awards-10x-genomics-permanent-injunction-in-patent-infringement-lawsuit-against-bruker-corporations-geomx-products-302338627.html SOURCE 10x Genomics, Inc.President-elect Trump wants to again rename North America’s tallest peak
Arkansas visits skidding Miami in battle of veteran coachesNetflix Just Hit 5th Record High In A Row: Looking For The Best Stocks To Buy And Watch? Check These Lists
None